Literature DB >> 1833972

Epidemiology of Down syndrome in South Australia, 1960-89.

A J Staples1, G R Sutherland, E A Haan, S Clisby.   

Abstract

During 1960-89 687 Down syndrome live births and 46 Down syndrome pregnancy terminations were identified in South Australia. Ascertainment was estimated to be virtually complete. The sex distribution of Down syndrome live births was found to be statistically different from the non-Down syndrome live-birth sex distribution (P less than .01). Smoothed maternal age-specific incidence was derived using both maternal age calculated to the nearest month and a discontinuous-slope regression model. The incidence of Down syndrome at birth for the study period was estimated to be 1.186 Down syndrome births/1,000 live births. Annual population incidence was shown to be correlated with trends in the maternal age distribution of confinements. If current trends in the maternal age distribution of confinements continue, the population incidence of Down syndrome in South Australia is predicted to exceed 1.5 Down syndrome births/1,000 live births during the 1990-94 quinquennium.

Mesh:

Year:  1991        PMID: 1833972      PMCID: PMC1683237     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  7 in total

1.  Frequency of Down syndrome in livebirths by single-year maternal age interval: results of a Massachusetts study.

Authors:  E B Hook; J J Fabia
Journal:  Teratology       Date:  1978-06

2.  Estimated rates of Down syndrome in live births by one year maternal age intervals for mothers aged 20-49 in a New York State study-implications of the risk figures for genetic counseling and cost-benefit analysis of prenatal diagnosis programs.

Authors:  E B Hook; G M Chambers
Journal:  Birth Defects Orig Artic Ser       Date:  1977

3.  Down syndrome in live births by single year maternal age interval in a Swedish study: comparison with results from a New York State study.

Authors:  E B Hook; A Lindsjö
Journal:  Am J Hum Genet       Date:  1978-01       Impact factor: 11.025

4.  Maternal serum screening for Down's syndrome in early pregnancy.

Authors:  N J Wald; H S Cuckle; J W Densem; K Nanchahal; P Royston; T Chard; J E Haddow; G J Knight; G E Palomaki; J A Canick
Journal:  BMJ       Date:  1988-10-08

5.  Comparison of mathematical models for the maternal age dependence of Down's syndrome rates.

Authors:  S H Lamson; E B Hook
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

6.  Down's syndrome: percentage reporting on birth certificates and single year maternal age risk rates for Ohio 1970-79: comparison with upstate New York data.

Authors:  C A Huether; G R Gummere; E B Hook; P S Dignan; H Volodkevich; M Barg; D A Ludwig; S H Lamson
Journal:  Am J Public Health       Date:  1981-12       Impact factor: 9.308

7.  Chromosome abnormalities and spontaneous fetal death following amniocentesis: further data and associations with maternal age.

Authors:  E B Hook
Journal:  Am J Hum Genet       Date:  1983-01       Impact factor: 11.025

  7 in total
  4 in total

1.  International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age.

Authors:  A D Carothers; C A Hecht; E B Hook
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

2.  Increasing total prevalence rate of cases with Down syndrome in Hungary.

Authors:  Julia Métneki; Andrew E Czeizel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Maternal age specific risk rate estimates for Down syndrome among live births in whites and other races from Ohio and metropolitan Atlanta, 1970-1989.

Authors:  C A Huether; J Ivanovich; B S Goodwin; E L Krivchenia; V S Hertzberg; L D Edmonds; D S May; J H Priest
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

4.  Direct health care costs of children and adolescents with Down syndrome.

Authors:  Elizabeth A Geelhoed; Ami Bebbington; Carol Bower; Aditya Deshpande; Helen Leonard
Journal:  J Pediatr       Date:  2011-07-23       Impact factor: 4.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.